J&J's Covid Vaccine

Photo: The Conversation

DCGI Approves J&J's Single-Shot COVID-19 Vaccine In India

Big Pharma Johnson &Johnson's to roll out its single-shot Covid Vaccine in India by the next month. Besides, it is being manufactured at 'Biological E' in Hyderabad. However, the officials have received Emergency Use Approval (EUA) from DCGI. Moreover, Vaccine batches will be sent to Central Drugs Laboratory (CDL) and National Centre for Cell Science (NCCS) for final testing by next week.

Thu, 09 Sep 2021 - 06:00 PM / by Athira Chandran

Tags: Covid Vaccine, Johnson & Johnson, Pharmaceutical, Biological E

Courtesy: News 18

Johnson and Johnson vaccine

Photo: Reuters

J&J Seeks Study For Its Vaccine To Be Applied On Adolescents In India

According to the statement given by the US-based pharmaceutical company, Johnson & Johnson notified that it has looked into the approval of the Central Drugs Standard Control Organisation to conduct a study on its Covid-19 vaccine for adolescents between 12-17 years old in India. Being “imperative”, all the nationals including children should be vaccinated against Covid-19 sooner. Besides, their vaccine is 85% effective in presenting… read-more

Fri, 20 Aug 2021 - 02:42 PM / by Ettishree Shukla

Tags: Covid -19, Coronavirus Vaccines, Johnson & Johnson, India

Courtesy: Zee News

Johnson and Johnson

Photo: DNA

J&J Covid-19 Vaccine Approved For Emergency Use In India

Johnson & Johnson’s single-shot Covid-19 vaccine has been approved for emergency use by India on August 7 amid the growing fear of the upcoming third wave. Health Minister took to Twitter saying, “India expands its vaccine basket! Johnson and Johnson's single-dose Covid-19 vaccine is given approval for Emergency Use in India.” However, the date of arrival of the doses has not been confirmed yet.

Sat, 07 Aug 2021 - 08:42 PM / by Umang Bafna

Tags: Johnson & Johnson, Covid-19 Vaccination centre, Covid-19

Courtesy: The Khaleej Times

Covid-19 vacccine vials.

Photo: DNA

Johnson & Johnson Seeks Approval For Single-Dose Vaccine Launch

US-based pharmaceutical company Johnson & Johnson (J&J) to likely launch a single-dose vaccine against COVID-19 for emergency use in India. Reportedly, the government is yet to approve the proposal. The company also said they aim to launch the vaccine in collaboration with Hyderabad-based Biological E Limited. Notably, the vaccine's phase three clinical trial shows an efficiency of 85% against the Covid-19 strain.

Fri, 06 Aug 2021 - 05:47 PM / by Brijesh Goswami

Tags: Johnson & Johnson, Covid-19 Vaccine, Single-dose, Indian government, vaccine

Courtesy: Scroll.in

Drug companies charges for mismanagement

Photo: Healio

US Drug Companies To Pay Billions In Historical Opioids Settlement

A group of 15 US state attorneys general negotiated a settlement deal from large drug companies for $26 billion for allegedly distributing addictive drugs and opioids. The deal became the second-largest cash settlement ever, after the $246 billion tobacco agreement in 1998. Under the deal, the three largest US drug distributors, McKesson Corp, Cardinal Health Inc, and AmerisourceBergen Corp would pay a combined $21bn, while Johnson &… read-more

Thu, 22 Jul 2021 - 09:24 PM / by Prateek Chakradhar

Tags: United States, Johnson & Johnson, Drugs, Attorney General, corporate, health care, Medical Supplies

Courtesy: The Guardian

Johnson and Johnson

Photo: Vox

Traces Of Benzene That Causes Cancer Found In J&J Sunscreens

Johnson & Johnson (J&J) on July 14 said it will recall five of its sunscreen products after benzene, a cancer-causing agent, was detected in its samples. "We voluntarily decided to recall them out of an abundance of caution," J&J said in a statement. Investigations are underway to find out how these chemicals were used in the products. Meanwhile, J&J has requested to stop the usage of the five sunscreens immediately.

Thu, 15 Jul 2021 - 12:07 PM / by Umang Bafna

Tags: Johnson & Johnson, Sunscreen, Cancer, Benzene Chemical

Courtesy: ABC NEWS

Johnson and Johnson vaccine

Photo: Anchorage Daily News

Govt To Soon Approve J&J's Single Dose COVID Jabs At Reasonable Price

India’s principal scientific advisor and co-chair of COVID-19 vaccine task force, K Vijay Raghavan has expected that Centre will soon approve the Johnson and Johnson’s COVID vaccine. Assuring that the pricing and availability will be made transparent, Raghavan hoped the vaccine’s capacity to increases exponentially as Centre looks to boost manufacturing and export of vaccines. J&J recently applied to conduct phase-III clinical trials of… read-more

Tue, 20 Apr 2021 - 07:30 PM / by Sohini Mandal

Tags: Johnson & Johnson, Corona Virus Vaccine, Indian government, COVID-19 outbreak

Courtesy: The Economic Times

Representational image

Photo: Times Of India

Johnson & Johnson Seeks Centre's Nod To Test Single-Shot COVID Vaccine

World’s only single-shot COVID-19 vaccine, manufactured by Johnson & Johnson, will soon undergo clinical trials in India. Reportedly, J&J have sought permission from CDSCO (Central Drugs Standard Control Organisation) to start bridging clinical trials with a small number of participants. Moreover, it has partnered with Biological E to broaden its manufacturing in India. Notably, the bridging trials prove only the safety and… read-more

Fri, 09 Apr 2021 - 11:32 AM / by Neha Sanjeev

Tags: Johnson & Johnson, Covid-19, USA, India, Covid Vaccine

Courtesy: The Indian Express

Johnson- covid vaccine

Photo: India TV News

J&J Puts COVID-19 Vaccine Trials On Hold After Participant Reports Illness

Johnson & Johnson's clinical trials for a COVID-19 vaccine have been halted after an illness reported by one of the participants of the trial. Though the company has not revealed the exact nature of the illness, it has said that the illness is being reviewed by an independent board and their physicians. Experts opine that such incidents are common during the trials of a vaccine. 

Tue, 13 Oct 2020 - 02:05 PM / by Sneha Ramesh

Tags: Johnson & Johnson, Covid-19, Coronavirus Vaccines, clinical trial

Courtesy: CNN

Johnson- covid vaccine

Photo: PharmaShots

Oxford Vaccine Scare Affects Johnson & Johnson COVID Vaccine Trial

Few volunteers in 'Johnson & Johnson COVID-19 Vaccine trial' have dropped out citing adverse effects reported during Oxford's vaccine trial. Speaking in an interview, Alberto Borobia, the lead investigator, said that few volunteers from Spain have walked out and few others have been concerned about the risk and fear that the 'Oxford incident' could get repeated. However, he confirmed that they had enough volunteers to continue the trials… read-more

Wed, 16 Sep 2020 - 09:06 AM / by Sneha Ramesh

Tags: health care, Coronavirus Vaccines, Johnson & Johnson, Spain.

Courtesy: The Economic Times